MedTrace Logo

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

NCT00932581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2023-04-07

No results posted yet for this study

Summary

The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.

Conditions

Interventions

OTHER

Bradykinesia UPDRS Motor Full Examination

The first group will receive the full motor examination section in its original order.

OTHER

Bradykinesia subscale of UPDRS Motor Examination

The second group will receive the bradykinesia subscale first followed by the remainder of the motor examination section.

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Buck, PhD, MPH · Teva Neuroscience, Inc.

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-11-30
Completion
2009-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932581 on ClinicalTrials.gov